Cardinal Health, Inc. $CAH Shares Sold by SG Americas Securities LLC

SG Americas Securities LLC decreased its holdings in Cardinal Health, Inc. (NYSE:CAH) by 75.3% during the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 18,516 shares of the company’s stock after selling 56,545 shares during the period. SG Americas Securities LLC’s holdings in Cardinal Health were worth $2,906,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of the business. MassMutual Private Wealth & Trust FSB increased its position in shares of Cardinal Health by 3.6% in the second quarter. MassMutual Private Wealth & Trust FSB now owns 1,767 shares of the company’s stock worth $297,000 after acquiring an additional 62 shares in the last quarter. Kathmere Capital Management LLC boosted its position in Cardinal Health by 1.6% during the 3rd quarter. Kathmere Capital Management LLC now owns 4,091 shares of the company’s stock worth $642,000 after purchasing an additional 65 shares during the period. Empirical Financial Services LLC d.b.a. Empirical Wealth Management boosted its position in Cardinal Health by 0.4% during the 2nd quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 17,805 shares of the company’s stock worth $2,991,000 after purchasing an additional 69 shares during the period. Vermillion & White Wealth Management Group LLC increased its holdings in Cardinal Health by 55.0% in the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 200 shares of the company’s stock valued at $34,000 after purchasing an additional 71 shares in the last quarter. Finally, Perigon Wealth Management LLC raised its position in Cardinal Health by 3.2% in the second quarter. Perigon Wealth Management LLC now owns 2,314 shares of the company’s stock valued at $389,000 after purchasing an additional 72 shares during the period. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Cardinal Health Price Performance

NYSE CAH opened at $202.42 on Tuesday. The company has a market capitalization of $48.10 billion, a price-to-earnings ratio of 30.53, a price-to-earnings-growth ratio of 1.46 and a beta of 0.65. Cardinal Health, Inc. has a 12 month low of $119.25 and a 12 month high of $214.93. The company’s fifty day moving average price is $204.29 and its two-hundred day moving average price is $173.48.

Cardinal Health (NYSE:CAH) last issued its earnings results on Thursday, October 30th. The company reported $2.55 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.22 by $0.33. Cardinal Health had a net margin of 0.68% and a negative return on equity of 84.37%. The business had revenue of $64.01 billion for the quarter, compared to analyst estimates of $59.41 billion. During the same quarter in the prior year, the business posted $1.88 EPS. The company’s revenue for the quarter was up 22.4% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. As a group, analysts anticipate that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd will be issued a dividend of $0.5107 per share. This represents a $2.04 dividend on an annualized basis and a yield of 1.0%. The ex-dividend date of this dividend is Friday, January 2nd. Cardinal Health’s dividend payout ratio (DPR) is currently 30.77%.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on CAH. Deutsche Bank Aktiengesellschaft upped their target price on Cardinal Health from $195.00 to $208.00 and gave the stock a “hold” rating in a research report on Tuesday, November 18th. Argus upped their price target on Cardinal Health from $189.00 to $211.00 and gave the stock a “buy” rating in a report on Tuesday, November 4th. Weiss Ratings reiterated a “buy (b)” rating on shares of Cardinal Health in a research note on Wednesday, October 8th. Mizuho set a $222.00 target price on shares of Cardinal Health in a research report on Monday. Finally, Wall Street Zen raised shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a report on Saturday, November 8th. Fourteen equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $213.40.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.